Present your results for the GC-MS analysis, commenting on your identification for the 3 samples. Remember to include details of any additional analysis which you may have undertaken, including the reasons why this was performed
1
2
1 Salicylic acid, isopropyl ether isopropyl ester Formula C13H1803, MW 222, CAS#NA, Entry# 101816 3:28NUNWAYXSHFLFAO-UHFFFAOYSAN Hit 1 1 2 3 O - 5 6 7 8 9 9 10 11 12 13 S! RSD Prob 854 985 3489 850 934 2947 832 972 1520 332 889 15.20 328 902 29.47 825 947 3489 820 941 34 89 814 876 2947 810 929 15.20 803 928 15.20 600 916 15.20 79 654 2947 767 836 29.47 Name Library Name Banro replo Aspinn replo Benzo. teplo Soliny traini Aspinn teplo Benzo mainlit Benzo repib Aspinn repih Benzo. mainit Benza.. replib Benzerelib Aspirin maintia Asprin replib Randata Library entry 120 100- NL 9 99E2 MKS MIN1047 RI 2.71 AV: 11.El Full ms[100000-400.000 90 100 HO- 80 703 . 80 50- 50 40 121 138 40- 30 20 180 20 180 10 163 139 195 199 200 232 253 121 107 117 135 151 163 281 313 327 346 985 premo Terrasse sowa 210 211 252 253 255 281 107 117 120 313 327 346 0 100 11 90 NL 9.99E2 SI 832 RSI SDS mainiit, Entry 101R16 CASO NA 5abcylic acid Isopropyl ether, Isopropyl ester 20- 80 1701 40- -50 50 138 Sa 40 -30- 30 20 92 -100 41 43 55 72 93 153 100 147 207 222 200 T 250 1111 20 40 60 100 120 140 160 180 220 TTTTTTTTTTTTTTTTT 240 260 280 300 320 340 360 385 50 100 150 300 200 mit 350 Acetaminophen Formula CaHONO2 MW 151, CAS# 103-10 2 Entry 17367 Acetamide, N.4 hydroxyphenya- -NH HO HS Prob 1 827 9734291 2 327 964 4291 3 919 976 3201 4 919 956 4291 5 906 939 42.91 5 902 944 4291 7 891 927 4291 3 88 941 8.55 9 BE -920 10 871 926 8 22 11 867 919 955 12 358 897 2:37 Nam Acetaminophen Acetaminopher Fyndinemohol ocente (esten Acetaminophen Acetaminophen Acetaminopher Acetaminophen Benzenemine, 4-propoxy Metacetamol Metected Benzenemine, propony pisopropoxyanine Library Name lepib replin manib Teplib mointi Teb epib manib month recib recib mersib Raw data-Library entry 100 300- 100 50 NL 9.99E2 sample1141 RT 4.02 AV 1 T. CE Fums 100.000- 400 0001 80 80 70 50 50 151 40 20- 10 103 110 107 119 135 109 152 185 197 207 251 259 281 282 151 152 179 197 207 327 341 105 107 119 12 222 253 269 281 327 100 90 N 999 SI 927 RS 973 replit, Entry# 17367, CASH 103-90-2 Acetaminophen -20 80 70 40- 60 151 -80 80 50 18 109 81 110 5463 92 94 122 135 -100 10 152 40 60 80 300 120 140 16 TO 200 TTTTT 240 290 100 220 150 320 341 200 250 300 300 RT 9.00 -552 100 4.03 NL 5.94E7 TIC MS sampled 90 80 70 60 50 40 6.45 5.51 624 5.30 30 603 6.09 20 1.16 1.17 4.11 10 415 421 0.21 0 29 0.58 0.70 0.95 1 46 1,50 165 187 2.14 Ae 250 258 279 294 3.18 3.40 3.58 368 3.93 5.84 5.91 465 503 5.19 5.36 5.5 5.63 0 GE 00 0.5 110 1.5 20 25 3.0 3.5 40 4.5 5.0 55 60 6 Time (min) ample 1141 RT 4.02 AV 1 NL 2.24E7 T +cal Ful ms (100.000 400.000 10903 100 90 80 70 60 50 40 151 07 30 20 10 110.10 110,13 135.11 149 05 0 100 152 11 165.08 170.02 160 180 197 11 207.04 22300 232 27 238 65 253 06 267.04 201.09 299,05 120 140 315.06 326 90 341.00 200 355 28 220 240 260 280 373 05 386 90 399 36 380 300 320 340 360 miz Hit Ibuprofen Formula 131802, MW 206 CAS# 15687 27-1 Entry# 24962 Benzenracec acid -methyl-4-2-methylpropy 1 5 6 7 E 9 10 11 12 13 SI 838 823 BIE B12 303 800 653 6-16 642 642 640 523 522 RS 931 93 831 883 663 2 710 725 709 200 698 709 678 Prob 58.99 35.75 3575 65.79 3575 3525 078 060 0.50 0.50 345 0.25 0.24 Name Library Nome 2146 maila Ibueno Ibupro Talib mr lib ibupro repla Ibupro repib Ibupro mamit 7 phe minib bupra maini ibupro einlit Ibupro mointi 4 4 Buty moinib foupro... menab OH 161 Raw dala - Library entry 100 90 NI 9.99E2 sampleŃ RT. 3.08 AV 1 T - El Fullms 100 000 400.000 100- 80 70 80- 60 80- 50 117 110 107 206 40 40- 30 10 20 164 145 105 10- 102 120 207 188 101 .65 208 234 253 263 281 283 325 327 346 357 145 160 117 135 188 179 101 102__ 390 207 0 100 234 253 263 281 283 325 327 331 357 371 329 151 90 163 NL 9.9902 SI 823 RSI 934 Teplih Entry# 24962 CASN 15687 271 ibuprofen -20- 20- 91 70 80 -40- 50 117 119 206 -50- 40 30 -20- 104 120 45 100 207 20 410 77 105 10- 51 178 92 LI 50 100 165 193 150 50 200 250 TTTT 350 100 150 300 TTTTTT 200 miz 250 300 350 390 NL 3.89 RT 0.00 -6.52 100 2757 66.39 TIC MS 6.37 Sample 6.31 6.24 6.20 w 80 8 8 8 8 8 8 607 615 GO Reative Abundance 6.00 591 5.88 5.81 50 1.15 1.18 3.94 M 3.97 400 123 1 25 Y411 420 439 4.46 5.36 544 20- 439 446 467 5.13 5.18 1 46 W Wie www 10 4.50 165 1.94 2.15 2.49 2.60 3.00 3.07 022 0.30 0.56 0.78 335 3.57 380 383 114 0 0.0 0.5 1.0 1.5 2.0 25 3.0 3.5 40 45 5.0 5.5 60 6.5 Time (min) sampleB W1098 RT 3.88 AV 1 NL: 2.62E6 1. El Ful ms (100.000-400.000 100 161.17 90 80 163.11 70 60 50 117.09 107.08 206.16 40 30 20 164.13 10 120.12 145.10 160 15 146.12 207.17 135.00 188.15 165 17 195.06 253 07 263.19 208.14 222 93 234.18 281.02 296.90 0-1. 100 346 22 354.96 371.22 389.13 399 92 120 140 313.07 327.06 320 160 180 200 220 240 260 200 300 340 360 380 muz RT 000 -6.03 100- 3.71 90 80- 70 60 Relative Abundance 50 40 343 3.44 30 20 3.47 1.15 1.17 10 1.45 1,49 1,65 94 2.14 2.69 1 273 2.39 2.51 324 3.30 376 394 411 420 4.39 465 4 92 496 5.34 5.51 0- 0.0 021 0 39 0.52 0.71 0 87 0.96 0.5 1.0 $34 554 5.66 582 5.97 600 1.5 20 2.5 3.5 40 30 Time (hh) 4.5 5.0 55 6.0 MKsampleA #1047 RT. 3.71 AV 1 NL: 1 3967 T: + c El Full ms 100.000-400 000 12005 100- 90 BO 70 50 50 101 121 07 30 138 05 20 180 OG 10- 163.06 117 14 122.07 139 07 161 15 164.10 195 09 210 09 222.19 239.01 253 08 100 260 05 281 20 120 140 160 297 16 180 200 343 16 220 357.22 313 02 327.07 "T 20 240 370 86 387.11 395 260 280 300
